Vinson Robert K, Hales Barbara F
Department of Pharmacology and Therapeutics, McGill University, 3655 Promenade Sir-William-Osler, Montréal, Que., Canada H3G-1Y6.
Biochem Pharmacol. 2002 Aug 15;64(4):711-21. doi: 10.1016/s0006-2952(02)01252-2.
Uracil incorporation into DNA occurs under conditions that limit thymidine biosynthesis; uracil is removed by two isoforms of uracil DNA glycosylase (UNG; EC 3.2.2.3), UNG1 and UNG2. We hypothesize that UNG is important in protecting the mid-organogenesis stage [gestational day (GD) 10-12] rat conceptus against conditions that limit thymidine biosynthesis. Transcripts for both UNG isoforms were expressed highly in the yolk sac and embryo, increasing over 400% in the embryo between GD11 and 12. GD10 and 11 yolk sacs showed the highest levels of putatively active UNG2 protein, with little UNG1 protein. Moderate levels of UNG2 and UNG1 proteins were found in the embryo on GDs 10 through 12; no significant increase in either protein occurred on GD12. UNG activity was higher in yolk sac than embryo on GDs 10 and 11, mirroring protein levels. Exposure to the teratogen methotrexate (MTX) leads to nucleotide pool imbalance, uracil incorporation into DNA, and genotoxic stress-induced cell death. Concentration-dependent decreases in developmental growth parameters, decreased yolk sac vasculature, and malformations such as kinked tail and retarded limb development were observed in embryos exposed to MTX (0.5, 2.5, or 5 microM). UNG transcripts were elevated 30-40% in both yolk sac and embryo after a 6-hr culture with 0.5 microM MTX; however, protein expression and activity were unaffected. Thus, MTX exposure caused malformations but did not modify UNG protein expression or activity, indicating an inability to increase the removal of MTX-induced genotoxic damage. Furthermore, UNG expression was developmental stage- and tissue-specific; the discrepancy between transcript and protein levels suggests post-transcriptional regulation.
在限制胸苷生物合成的条件下,尿嘧啶会掺入DNA;尿嘧啶DNA糖基化酶(UNG;EC 3.2.2.3)的两种同工型UNG1和UNG2会将尿嘧啶去除。我们推测UNG在保护器官形成中期[妊娠日(GD)10 - 12]大鼠胚胎免受限制胸苷生物合成的条件影响方面很重要。两种UNG同工型的转录本在卵黄囊和胚胎中均高表达,在胚胎中从GD11到12增加超过400%。GD10和11的卵黄囊中显示出最高水平的假定有活性的UNG2蛋白,而UNG1蛋白很少。在GD10至12的胚胎中发现了中等水平的UNG2和UNG1蛋白;在GD12时,两种蛋白均未出现显著增加。在GD10和11时,卵黄囊中的UNG活性高于胚胎,这与蛋白水平一致。暴露于致畸剂甲氨蝶呤(MTX)会导致核苷酸池失衡、尿嘧啶掺入DNA以及基因毒性应激诱导的细胞死亡。在暴露于MTX(0.5、2.5或5微摩尔)的胚胎中,观察到发育生长参数呈浓度依赖性下降、卵黄囊血管系统减少以及诸如扭尾和肢体发育迟缓等畸形。在用0.5微摩尔MTX培养6小时后,卵黄囊和胚胎中的UNG转录本均升高30 - 40%;然而,蛋白表达和活性未受影响。因此,MTX暴露导致了畸形,但未改变UNG蛋白表达或活性,表明无法增加对MTX诱导的基因毒性损伤的清除。此外,UNG表达具有发育阶段和组织特异性;转录本和蛋白水平之间的差异表明存在转录后调控。